Biogen surges ahead of key FDA decision amid mixed views on potential Alzheimer’s therapy

seekingalpha2021-06-07

Biogen(NASDAQ:BIIB) rose ~5.0%on Friday to outperform the broader market for the week as it awaits FDA approval for aducanumab, the experimental therapy against Alzheimer’s disease co-developed by the...

Source Link

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

Gunners80
2021-06-07
Gunners80
To the moon if it gets approved.
HoldTheDoor
2021-06-07
HoldTheDoor
Like and comment
- Gunners80:
  cook
Derrick0359
2021-06-07
Derrick0359
Wow
- Gunners80:
  nice
- Zfron:
  Ok
- Derrick0359:
  Comment pls
Ashish
2021-06-07
Ashish
Pls like and cooment
- Aaronykc:
  Ok pls reply
Suba
2021-06-07
Suba
Looks good
- Gibbie:
  comment
Tslverde
2021-06-07
Tslverde
Good. Please like
- LennartM:
  sure comment me back
- Gibbie:
  comment
- Ashish:
  done

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/1179953695?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2021-06-07 10:25","share_image_url":"https://static.laohu8.com/5a36db9d73b4222bc376d24ccc48c8a4","id":"1179953695","market":"us","top_or_hot":-1,"title":"Biogen surges ahead of key FDA decision amid mixed views on potential Alzheimer’s therapy","media":"seekingalpha","content":"<div>\n<p>Biogen(NASDAQ:BIIB) rose ~5.0%on Friday to outperform the broader market for the week as it awaits FDA approval for aducanumab, the experimental therapy against Alzheimer’s disease co-developed by the...</p>\n\n<a href=\"https://seekingalpha.com/news/3703521-biogen-surges-ahead-of-key-fda-decision-amid-mixed-views-on-potential-alzheimers-therapy\">Source Link</a>\n\n</div>\n","source":"seekingalpha","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Biogen surges ahead of key FDA decision amid mixed views on potential Alzheimer’s therapy</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nBiogen surges ahead of key FDA decision amid mixed views on potential Alzheimer’s therapy\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-06-07 10:25 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://seekingalpha.com/news/3703521-biogen-surges-ahead-of-key-fda-decision-amid-mixed-views-on-potential-alzheimers-therapy><strong>seekingalpha</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Biogen(NASDAQ:BIIB) rose ~5.0%on Friday to outperform the broader market for the week as it awaits FDA approval for aducanumab, the experimental therapy against Alzheimer’s disease co-developed by the...</p>\n\n<a href=\"https://seekingalpha.com/news/3703521-biogen-surges-ahead-of-key-fda-decision-amid-mixed-views-on-potential-alzheimers-therapy\">Source Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"BIIB","symbol_name":"渤健公司","start_time":0,"source_url":"https://seekingalpha.com/news/3703521-biogen-surges-ahead-of-key-fda-decision-amid-mixed-views-on-potential-alzheimers-therapy","article_id":"1179953695","we_media_id":null,"thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1179953695","pubTimestamp":1623032758,"sourceInfo":{"source_id":"seekingalpha","name":"Seeking Alpha"},"weMediaInfo":null,"summary":"Biogen(NASDAQ:BIIB) rose ~5.0%on Friday to outperform the broader market for the week as it awaits F","collect":0,"end_time":0,"defaultTopTitle":"seekingalpha.com","property":[],"viewcount":null,"language":"en","relate_stocks":{"BIIB":"渤健公司"},"translate_title":"在对潜在的阿尔茨海默氏症疗法持不同观点的情况下，FDA的关键决定前生物原激增","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"BIIB":0.9},"content_text":"Biogen(NASDAQ:BIIB) rose ~5.0%on Friday to outperform the broader market for the week as it awaits FDA approval for aducanumab, the experimental therapy against Alzheimer’s disease co-developed by the company with Eisai(OTCPK:ESALF).While scientists question the efficacy of aducanumab which had a mixed performance in late-stage trials, the patient advocacy groups continue to stand behind the treatment.\"We support a decision for approval of aducanumab ... It ushers in a new era of potential treatments,\" Reuters quoted Dr. Joanne Pike, chief strategy officer at the Alzheimer's Association as saying.However, the analysts appear divided on the potential for aducanumab to secure a regulatory nod. Citing management comments over plans for its commercialization, Oppenheimer raised the probability of approval to 50% from 30%.Recently, Mizuho analyst Salim Syed estimated Biogen shares could reach ~$400 or ~$200 depending on the FDA decision.Meanwhile, Bank of America remains cautious with the analyst Geoff Meacham giving the treatment only a 25% chance of avoiding the FDA rejection.A positive decision by the FDA “could signal probably more regulatory flexibility,\" Meacham noted trying to predict the impact of the decision by the regulator which remains under the Acting Commissioner Janet Woodcock.Meanwhile, Seeking Alpha contributor Trent Welsh thinks that in the event of a negative outcome, the activist involvement could mitigate the losses for investors as the contributor initiates a very bullish view on Biogen ahead of the FDA action date for aducanumab on June 07.","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"0","news_tag":"","news_rank":0,"symbols":[],"gpt_button":1},"commentList":[{"id":114033729,"gmtCreate":1623034557161,"gmtModify":1704194724614,"author":{"id":"3568161254291931","authorId":"3568161254291931","name":"Gunners80","avatar":"https://static.tigerbbs.com/1b631d2d208e0248c96ed1117c4db37e","vip":1,"crmLevel":5,"crmLevelSwitch":1,"idStr":"3568161254291931","authorIdStr":"3568161254291931"},"htmlText":"To the moon if it gets approved.","listText":"To the moon if it gets approved.","text":"To the moon if it gets approved.","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/114033729","repostId":1179953695,"repostType":4,"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"langContent":"EN"},{"id":114097058,"gmtCreate":1623034353674,"gmtModify":1704194719282,"author":{"id":"3580469278772937","authorId":"3580469278772937","name":"HoldTheDoor","avatar":"https://static.tigerbbs.com/635db0f1af7cd6ef4ce184b75309a7b0","vip":1,"crmLevel":2,"crmLevelSwitch":0,"idStr":"3580469278772937","authorIdStr":"3580469278772937"},"htmlText":"Like and comment&nbsp;","listText":"Like and comment&nbsp;","text":"Like and comment","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":1,"repostSize":0,"link":"https://ttm.financial/post/114097058","repostId":1179953695,"repostType":4,"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"comments":[{"id":4610672,"gmtCreate":1623034567450,"gmtModify":1663228095634,"authorId":3568161254291931,"author":{"id":3568161254291931,"idStr":"3568161254291931","authorId":3568161254291931,"name":"Gunners80","avatar":"https://static.tigerbbs.com/1b631d2d208e0248c96ed1117c4db37e","vip":1,"currentWearingBadge":{"badgeId":"972123088c9646f7b6091ae0662215be-3","templateUuid":"972123088c9646f7b6091ae0662215be","name":"Legendary Trader","description":"Total number of securities or futures transactions reached 300","bigImgUrl":"https://static.tigerbbs.com/656db16598a0b8f21429e10d6c1cb033","smallImgUrl":"https://static.tigerbbs.com/03f10910d4dd9234f9b5702a3342193a","grayImgUrl":"https://static.tigerbbs.com/0c767e35268feb729d50d3fa9a386c5a","redirectLinkEnabled":0,"hasAllocated":1,"isWearing":1,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2024.05.26","exceedPercentage":"93.64%","individualDisplayEnabled":0,"individualDisplaySort":0,"categoryType":1100},"crmLevel":5,"crmLevelSwitch":1,"individualDisplayBadges":[]},"repliedAuthorId":0,"objectId":114097058,"type":1,"supId":0,"prevId":0,"content":"<u>cook</u>","text":"<u>cook</u>","html":"<u>cook</u>"}],"langContent":"EN"},{"id":114095701,"gmtCreate":1623034311103,"gmtModify":1704194717344,"author":{"id":"3574151642706297","authorId":"3574151642706297","name":"Derrick0359","avatar":"https://static.tigerbbs.com/1e4377b13ebe2fd65f630bf249fd6624","vip":1,"crmLevel":4,"crmLevelSwitch":0,"idStr":"3574151642706297","authorIdStr":"3574151642706297"},"htmlText":"Wow","listText":"Wow","text":"Wow","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":3,"commentSize":3,"repostSize":0,"link":"https://ttm.financial/post/114095701","repostId":1179953695,"repostType":4,"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"comments":[{"id":4610679,"gmtCreate":1623034600540,"gmtModify":1663228095536,"authorId":3568161254291931,"author":{"id":3568161254291931,"idStr":"3568161254291931","authorId":3568161254291931,"name":"Gunners80","avatar":"https://static.tigerbbs.com/1b631d2d208e0248c96ed1117c4db37e","vip":1,"currentWearingBadge":{"badgeId":"972123088c9646f7b6091ae0662215be-3","templateUuid":"972123088c9646f7b6091ae0662215be","name":"Legendary Trader","description":"Total number of securities or futures transactions reached 300","bigImgUrl":"https://static.tigerbbs.com/656db16598a0b8f21429e10d6c1cb033","smallImgUrl":"https://static.tigerbbs.com/03f10910d4dd9234f9b5702a3342193a","grayImgUrl":"https://static.tigerbbs.com/0c767e35268feb729d50d3fa9a386c5a","redirectLinkEnabled":0,"hasAllocated":1,"isWearing":1,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2024.05.26","exceedPercentage":"93.64%","individualDisplayEnabled":0,"individualDisplaySort":0,"categoryType":1100},"crmLevel":5,"crmLevelSwitch":1,"individualDisplayBadges":[]},"repliedAuthorId":0,"objectId":114095701,"type":1,"supId":4610618,"prevId":0,"content":"nice","text":"nice","html":"nice"},{"id":4610963,"gmtCreate":1623035916557,"gmtModify":1663228095430,"authorId":3573634322541563,"author":{"id":3573634322541563,"idStr":"3573634322541563","authorId":3573634322541563,"name":"Zfron","avatar":"https://static.tigerbbs.com/70ecdc2067440ea2fe4b2c600ae46f73","vip":1,"crmLevel":3,"crmLevelSwitch":1,"individualDisplayBadges":[]},"repliedAuthorId":0,"objectId":114095701,"type":1,"supId":4610618,"prevId":0,"content":"Ok","text":"Ok","html":"Ok"},{"id":4610618,"gmtCreate":1623034320612,"gmtModify":1663228093737,"authorId":3574151642706297,"author":{"id":3574151642706297,"idStr":"3574151642706297","authorId":3574151642706297,"name":"Derrick0359","avatar":"https://static.tigerbbs.com/1e4377b13ebe2fd65f630bf249fd6624","vip":1,"crmLevel":4,"crmLevelSwitch":0,"individualDisplayBadges":[]},"repliedAuthorId":0,"objectId":114095701,"type":1,"supId":0,"prevId":0,"content":"Comment pls","text":"Comment pls","html":"Comment pls"}],"langContent":"EN"},{"id":114000326,"gmtCreate":1623033349865,"gmtModify":1704194697948,"author":{"id":"3554959936968759","authorId":"3554959936968759","name":"Ashish","avatar":"https://static.tigerbbs.com/3be2c16a3f991c655e70424d200c7389","vip":1,"crmLevel":5,"crmLevelSwitch":1,"idStr":"3554959936968759","authorIdStr":"3554959936968759"},"htmlText":"Pls like and cooment","listText":"Pls like and cooment","text":"Pls like and cooment","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":4,"commentSize":1,"repostSize":0,"link":"https://ttm.financial/post/114000326","repostId":1179953695,"repostType":4,"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"comments":[{"id":4610383,"gmtCreate":1623033454979,"gmtModify":1663228097043,"authorId":3571535693267201,"author":{"id":3571535693267201,"idStr":"3571535693267201","authorId":3571535693267201,"name":"Aaronykc","avatar":"https://static.tigerbbs.com/a6fb0a4f08d4e7b8733e7ebc2445aad5","vip":1,"currentWearingBadge":{"badgeId":"972123088c9646f7b6091ae0662215be-2","templateUuid":"972123088c9646f7b6091ae0662215be","name":"Master Trader","description":"Total number of securities or futures transactions reached 100","bigImgUrl":"https://static.tigerbbs.com/ad22cfbe2d05aa393b18e9226e4b0307","smallImgUrl":"https://static.tigerbbs.com/36702e6ff3ffe46acafee66cc85273ca","grayImgUrl":"https://static.tigerbbs.com/d52eb88fa385cf5abe2616ed63781765","redirectLinkEnabled":0,"hasAllocated":1,"isWearing":1,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2023.07.14","exceedPercentage":"80.46%","individualDisplayEnabled":0,"individualDisplaySort":0,"categoryType":1100},"crmLevel":5,"crmLevelSwitch":1,"individualDisplayBadges":[]},"repliedAuthorId":0,"objectId":114000326,"type":1,"supId":0,"prevId":0,"content":"Ok pls reply","text":"Ok pls reply","html":"Ok pls reply"}],"langContent":"EN"},{"id":115771555,"gmtCreate":1623033079877,"gmtModify":1704194686588,"author":{"id":"3577997605150210","authorId":"3577997605150210","name":"Suba","avatar":"https://static.tigerbbs.com/053ae4273b989a37e570ad5f7b35a6d6","vip":1,"hat":"https://static.tigerbbs.com/f84d87792f02cf78e80ee34979fd31e5","crmLevel":7,"crmLevelSwitch":0,"idStr":"3577997605150210","authorIdStr":"3577997605150210"},"htmlText":"Looks good","listText":"Looks good","text":"Looks good","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":6,"commentSize":1,"repostSize":0,"link":"https://ttm.financial/post/115771555","repostId":1179953695,"repostType":4,"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"comments":[{"id":4610332,"gmtCreate":1623033328476,"gmtModify":1663228096737,"authorId":3564398446314499,"author":{"id":3564398446314499,"idStr":"3564398446314499","authorId":3564398446314499,"name":"Gibbie","avatar":"https://static.tigerbbs.com/ac29ad2a0a11289a908ae00b770dc0c5","vip":1,"crmLevel":6,"crmLevelSwitch":0,"individualDisplayBadges":[]},"repliedAuthorId":0,"objectId":115771555,"type":1,"supId":0,"prevId":0,"content":"comment","text":"comment","html":"comment"}],"langContent":"EN"},{"id":115773537,"gmtCreate":1623033041129,"gmtModify":1704194685452,"author":{"id":"3556329315079497","authorId":"3556329315079497","name":"Tslverde","avatar":"https://static.tigerbbs.com/5f52f5991ed363792008cd868f78181c","vip":1,"crmLevel":3,"crmLevelSwitch":0,"idStr":"3556329315079497","authorIdStr":"3556329315079497"},"htmlText":"Good. Please like","listText":"Good. Please like","text":"Good. Please like","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":5,"commentSize":3,"repostSize":0,"link":"https://ttm.financial/post/115773537","repostId":1179953695,"repostType":4,"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"comments":[{"id":4610334,"gmtCreate":1623033329162,"gmtModify":1663228095725,"authorId":3576017931077934,"author":{"id":3576017931077934,"idStr":"3576017931077934","authorId":3576017931077934,"name":"LennartM","avatar":"https://static.tigerbbs.com/2b888cf8f0c645e538df3ec026d3db37","vip":1,"crmLevel":4,"crmLevelSwitch":0,"individualDisplayBadges":[]},"repliedAuthorId":0,"objectId":115773537,"type":1,"supId":0,"prevId":0,"content":"sure comment me back","text":"sure comment me back","html":"sure comment me back"},{"id":4610339,"gmtCreate":1623033335856,"gmtModify":1663228094670,"authorId":3564398446314499,"author":{"id":3564398446314499,"idStr":"3564398446314499","authorId":3564398446314499,"name":"Gibbie","avatar":"https://static.tigerbbs.com/ac29ad2a0a11289a908ae00b770dc0c5","vip":1,"crmLevel":6,"crmLevelSwitch":0,"individualDisplayBadges":[]},"repliedAuthorId":0,"objectId":115773537,"type":1,"supId":0,"prevId":0,"content":"comment","text":"comment","html":"comment"},{"id":4610350,"gmtCreate":1623033361422,"gmtModify":1635334162335,"authorId":3554959936968759,"author":{"id":3554959936968759,"idStr":"3554959936968759","authorId":3554959936968759,"name":"Ashish","avatar":"https://static.tigerbbs.com/3be2c16a3f991c655e70424d200c7389","vip":1,"crmLevel":5,"crmLevelSwitch":1,"individualDisplayBadges":[]},"repliedAuthorId":0,"objectId":115773537,"type":1,"supId":4610339,"prevId":0,"content":"<u>done</u>","text":"<u>done</u>","html":"<u>done</u>"}],"langContent":"EN"}],"isCommentEnd":false,"newsSizeData":{"likeSize":58,"commentSize":6,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"deviceId":"web-server-community-laohu8-v3","version":"4.29.3","shortVersion":"4.29.3","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/1179953695"}